Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Lymphoma

Free Subscription Articles published in Blood Retrieve available abstracts of 222 articles: HTML format Text format

Single Articles

March 2010
1. YAMAZAKI J , Mizukami T, Hall WW, Hamaguchi I, et al
   Response: Estimating frequency of cancer stem cells in a mouse model of adult T-cell leukemia/lymphoma.
   Blood. 2010;115:2118.
   PubMed     Text format     Related articles   
   
   
   
2. BONNEFOIX T , Callanan M
   Challenging the adult T-cell leukemia/lymphoma (ATL) stem cell concept based on limiting dilution transplantation assay.
   Blood. 2010;115:2117-8.
   PubMed     Text format     Related articles   
   
   
   
3. GIURIATO S , Foisseau M, Dejean E, Felsher DW, et al
   Conditional TPM3-ALK and NPM-ALK transgenic micedevelop reversible ALK-positive early B cell lymphoma/leukemia.
   Blood. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. HIRATA Y , Hamanaka S, Onodera M
   Transactivation of the dopamine receptor 3 gene by a single provirus integration results in development of B cell lymphoma in transgenic mice generated from retrovirally transduced embryonic stem cells.
   Blood. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SARINA B , Castagna L, Farina L, Patriarca F, et al
   Allogeneic transplantation improves the overall and progression-free survival of Hodgkin's lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability.
   Blood. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. STERN M , Opelz G, Dohler B, Hess C, et al
   Natural killer cell receptor polymorphisms and post-transplant non-Hodgkin lymphoma.
   Blood. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. AUDARD V , Zhang SY, Copie-Bergman C, Rucker-Martin C, et al
   Occurrence of minimal change nephrotic syndrome in classical Hodgkin's lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.
   Blood. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. YECIES D , Carlson NE, Deng J, Letai A, et al
   Acquired resistance to ABT-737 in lymphoma cells that upregulate of MCL-1 and BFL-1.
   Blood. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. SIENIAWSKI M , Angamuthu N, Boyd K, Chasty R, et al
   Evaluation of enteropathy associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplant.
   Blood. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
10. MARKLEY JC , Sadelain M
    Interleukin (IL)-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T-cell-mediated rejection of systemic lymphoma in immunodeficient mice.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. AIT-TAHAR K , Damm-Welk C, Burkhardt B, Zimmermann M, et al
    Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. FAN G , Simmons MJ, Ge S, Dutta-Simmons J, et al
    Defective ubiquitin-mediated degradation of anti-apoptotic Bfl-1 predisposes to lymphoma.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CHEN WC , Completo GC, Sigal DS, Crocker PR, et al
    In vivo targeting of B-cell lymphoma with glycan ligands of CD22.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. XUAN C , Steward KK, Timmerman JM, Morrison SL, et al
    Targeted delivery of interferon alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. GISSELBRECHT C
    Molecular signatures in T-cell lymphoma.
    Blood. 2010;115:919-20.
    PubMed     Text format     Related articles   
    
    
    
16. FRENZEL A , Labi V, Chmelewskij W, Ploner C, et al
    Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.
    Blood. 2010;115:995-1005.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. HESLOP HE , Slobod KS, Pule MA, Hale GA, et al
    Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.
    Blood. 2010;115:925-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. DUNLEAVY K , Little RF, Pittaluga S, Grant N, et al
    The role of tumor histogenesis, FDG-PET, and short course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LAMBERT JR , Bomanji JB, Peggs KS, Thomson KJ, et al
    Prognostic role of PET scanning before and after reduced intensity allogeneic stem cell transplant for lymphoma.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. BANERJEE P , Tripp A, Lairmore MD, Crawford L, et al
    Adult T cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
21. HAYNES RA 2ND , Ware E, Premanandan C, Zimmerman B, et al
    Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.
    Blood. 2010;115:815-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. LANCA T , Correia DV, Moita CF, Raquel H, et al
    The MHC class Ib protein ULBP1 is a non-redundant determinant of leukemia/ lymphoma susceptibility to {gamma}{delta} T-cell cytotoxicity.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. ALDINUCCI D , Pinto A, Gloghini A, Carbone A, et al
    Chemokine receptors as therapeutic tools in Hodgkin lymphoma: CCR4 and beyond.
    Blood. 2010;115:746-7.
    PubMed     Text format     Related articles   
    
    
    
24. SAROSIEK KA , Malumbres R, Nechushtan H, Gentles AJ, et al
    Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.
    Blood. 2010;115:570-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. SCHLIEMANN C , Roesli C, Kamada H, Borgia B, et al
    In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.
    Blood. 2010;115:736-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. ZHAO JJ , Lin J, Lwin T, Yang H, et al
    microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
27. GEISLER CH , Kolstad A, Laurell A, Raty R, et al
    The Mantle Cell Lymphoma Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive 1st-line immunochemotherapy and autologous stem-cell transplantation (ASCT).
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. POTT C , Hoster E, Delfau-Larue MH, Beldjord K, et al
    Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. SPARANO JA , Lee JY, Kaplan LD, Levine AM, et al
    Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated, B-cell non-Hodgkin's lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. GATT ME , Grisaro S
    Central nervous system prophylaxis in mantle cell lymphoma.
    Blood. 2009;114:5402-3.
    PubMed     Text format     Related articles   
    
    
    
31. JUSZCZYNSKI P , Chen L, O'Donnell E, Polo JM, et al
    BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
    Blood. 2009;114:5315-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
32. HUANG Y , de Reynies A, de Leval L, Ghazi B, et al
    Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal-type.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. MURGA PENAS EM , Callet-Bauchu E, Ye H, Gazzo S, et al
    The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LIN YW , Beharry ZM, Hill EG, Song JH, et al
    A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. DI BELLA N , Taetle R, Kolibaba K, Boyd T, et al
    Results of a phase II study of bortezomib in patients with relapsed or refractory indolent lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. IQBAL J , Weisenburger DD, Greiner TC, Vose JM, et al
    Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. FRIEDBERG JW , Sharman J, Sweetenham J, Johnston PB, et al
    Inhibition of Syk with fostamatinib disodium has significant clinical activity in non Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. CRAIG VJ , Arnold I, Gerke C, Huynh MQ, et al
    Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. SCHMITZ N , Sureda A, Dini G, Claviez A, et al
    Allogeneic transplantation for children and adolescents with Hodgkin lymphoma.
    Blood. 2009;114:4605-6.
    PubMed     Text format     Related articles   
    
    
    
40. WANG H , Liu Y, Li ZY, Fan X, et al
    A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. FARINHA P , Al-Tourah A, Gill K, Klasa R, et al
    The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. BOUAZIZ JD , Cordel N, Hickman G, Fieschi C, et al
    Cutaneous tumor lysis syndrome in a patient with HTLV-1 adult T-cell lymphoma/leukemia.
    Blood. 2009;114:4320-1.
    PubMed     Text format     Related articles   
    
    
    
43. MCKELLER MR , Robetorye RS, Dahia PL, Aguiar RC, et al
    Integrity of the CBL gene in mature B-cell malignancies.
    Blood. 2009;114:4321-2.
    PubMed     Text format     Related articles   
    
    
    October 2009
44. KUPPERS R
    Clonotypic B cells in classic Hodgkin lymphoma.
    Blood. 2009;114:3970-1.
    PubMed     Text format     Related articles   
    
    
    
45. ROSSI EA , Goldenberg DM, Cardillo TM, Stein R, et al
    CD20-targeted tetrameric interferon-alpha, a novel and potent immunocytokine for the therapy of B-cell lymphomas.
    Blood. 2009;114:3864-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. PONZONI M , Dolcetti R, Doglioni C, Ferreri AJ, et al
    Bugs and marginal zone lymphoma of the ocular adnexae: is the future already here?
    Blood. 2009;114:3499.
    PubMed     Text format     Related articles   
    
    
    
47. LI B , Zhao L, Guo H, Wang C, et al
    Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. WANG ZY , Li YX, Wang WH, Jin J, et al
    Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
49. RAMSAY AG , Clear AJ, Kelly G, Fatah R, et al
    Follicular lymphoma cells induce T-cell immunological synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HORNING SJ , Juweid ME, Schoder H, Wiseman G, et al
    Interim positron emission tomography (PET) scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. VARGHESE B , Widman A, Do J, Taidi B, et al
    Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. KLAPPROTH K , Sander S, Marinkovic D, Baumann B, et al
    The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
    Blood. 2009;114:2448-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. HONMA K , Tsuzuki S, Nakagawa M, Tagawa H, et al
    TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
    Blood. 2009;114:2467-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. QIN H , Cha SC, Neelapu SS, Lou Y, et al
    Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T-cell, and not B-cell, dependent anti-lymphoma immunity.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. DOLCETTI R , De Paoli P, Serraino D
    Degree of immune suppression and risk of HIV-related Hodgkin lymphoma: time points matter.
    Blood. 2009;114:2354.
    PubMed     Text format     Related articles   
    
    
    
56. JOHNSON NA , Savage KJ, Ludkovski O, Ben-Neriah S, et al
    Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.
    Blood. 2009;114:2273-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. COZEN W , Hamilton AS, Zhao P, Salam MT, et al
    A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. MOTTOK A , Renne C, Seifert M, Oppermann E, et al
    Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B cell lymphoma entities.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. 
    Hypereosinophilia.
    Blood. 2009;114:2014.
    PubMed     Text format     Related articles   
    
    
    August 2009
60. TETA MJ , Wagner ME
    Consistency and synergy.
    Blood. 2009;114:2000-1.
    PubMed     Text format     Related articles   
    
    
    
61. DIETRICH PY
    Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error?
    Blood. 2009;114:1999.
    PubMed     Text format     Related articles   
    
    
    
62. SCHMITZ N , Zeynalova S, Loeffler M, Pfreundschuh M, et al
    Response: Intrathecal methotrexate and central nervous system events.
    Blood. 2009;114:1999-2000.
    PubMed     Text format     Related articles   
    
    
    
63. SAVAGE KJ , Johnson NA, Ben-Neriah S, Connors JM, et al
    MYC gene re-arrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. LI Z , Wang H, Xue L, Shin DM, et al
    E{micro}-BCL10 mice exhibit constitutive activation of both canonical and non-canonical NF-{kappa}B pathways generating marginal zone (MZ) B cell expansion as a precursor to splenic MZ lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. LIM MS , Carlson ML, Crockett DK, Fillmore GC, et al
    The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways.
    Blood. 2009;114:1585-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. LEVINE AM
    Stem cell transplantation in AIDS-lymphoma.
    Blood. 2009;114:1284-5.
    PubMed     Text format     Related articles   
    
    
    
67. COSTINEAN S , Sandhu SK, Pedersen IM, Tili E, et al
    Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.
    Blood. 2009;114:1374-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. NAVARRO A , Diaz T, Martinez A, Gaya A, et al
    Regulation of JAK2 by miR-135a: prognostic impact in classical Hodgkin lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. 
    Intravascular lymphoma.
    Blood. 2009;114:1140.
    PubMed     Text format     Related articles   
    
    
    
70. GREEN DJ , Pagel JM, Nemecek ER, Lin Y, et al
    Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.
    Blood. 2009;114:1226-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
71. GUPTA M , Ansell SM, Novak AJ, Kumar S, et al
    Inhibition of histone deacetylase overcomes rapamycin- mediated resistance in diffuse large B cell lymphoma by inhibiting Akt signaling through mTORC2.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. HOUOT R , Goldstein MJ, Kohrt HE, Myklebust JH, et al
    Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. YAMANAKA Y , Tagawa H, Takahashi N, Watanabe A, et al
    Aberrant overexpression of microRNAs activate AKT signaling via downregulation of tumor suppressors in NK-cell lymphoma/leukemia.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. PURDUE MP , Lan Q, Martinez-Maza O, Oken MM, et al
    A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. GENTLES AJ , Alizadeh AA, Lee SI, Myklebust JH, et al
    A pluripotency signature predicts histological transformation and influences survival in follicular lymphoma patients.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. DORNAN D , Bennett F, Chen Y, Dennis M, et al
    Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin's lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. LEICH E , Salaverria I, Bea S, Zettl A, et al
    Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
    Blood. 2009;114:826-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. MIDDENDORP S , Xiao Y, Song JY, Peperzak V, et al
    Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B cell lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. ZAHEEN A , Boulianne B, Parsa JY, Ramachandran S, et al
    AID constrains germinal center size by rendering B cells susceptible to apoptosis.
    Blood. 2009;114:547-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. UEFFING N , Singh KK, Christians A, Thorns C, et al
    A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein.
    Blood. 2009;114:572-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. THOLOULI E , Watt S, Lucas GS, Burthem J, et al
    Stage IV adult sporadic Burkitt lymphoma/leukemia with complex bone marrow cytogenetics is associated with a very poor outcome.
    Blood. 2009;114:485-6.
    PubMed     Text format     Related articles   
    
    
    
82. ELLIS L , Bots M, Lindemann RK, Bolden JE, et al
    The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy.
    Blood. 2009;114:380-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. YAMAZAKI J , Mizukami T, Takizawa K, Kuramitsu M, et al
    Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T- cell leukemia / lymphoma (ATL).
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. SCHWARTZ CL , Constine LS, Villaluna D, London WB, et al
    A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate and high risk Hodgkin lymphoma: the results of P9425 from the Children's Oncology Group.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. TSAI SC , Lin SJ, Chen PW, Luo WY, et al
    EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.
    Blood. 2009;114:109-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
86. GHIELMINI M , Zucca E
    How I treat mantle cell lymphoma.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. LI C , Kim SW, Rai D, Bolla AR, et al
    Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.
    Blood. 2009;113:6681-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. DI STASI A , De Angelis B, Rooney CM, Zhang L, et al
    T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
    Blood. 2009;113:6392-402.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. SUZUKI R , Suzumiya J, Oshimi K
    Differences between nasal and extranasal NK/T-cell lymphoma.
    Blood. 2009;113:6260-1.
    PubMed     Text format     Related articles   
    
    
    
90. SMITH C , Wakisaka N, Crough T, Peet J, et al
    Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation.
    Blood. 2009;113:6148-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. KIM SW , Rai D, McKeller MR, Aguiar RC, et al
    Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL.
    Blood. 2009;113:6153-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. REN M , Li X, Cowell JK
    Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-FGFR1 chimeric tyrosine kinase.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. GASCOYNE RD
    Stem cells in Hodgkin lymphoma?
    Blood. 2009;113:5694.
    PubMed     Text format     Related articles   
    
    
    
94. CLAVIEZ A , Canals C, Dierickx D, Stein J, et al
    Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin's lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.
    Blood. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. ILLIDGE T , Du Y
    When is a predose a dose too much?
    Blood. 2009;113:6034-5.
    PubMed     Text format     Related articles   
    
    
    
96. CHANG HC , Han L, Goswami R, Nguyen ET, et al
    Impaired development of human Th1 cells in patients with deficient expression of STAT4.
    Blood. 2009;113:5887-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
97. KOHLHOF H , Hampel F, Hoffmann R, Burtscher H, et al
    Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
    Blood. 2009;113:5506-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. CI W , Polo JM, Cerchietti L, Shaknovich R, et al
    The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.
    Blood. 2009;113:5536-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. CUI YX , Kerby A, McDuff FK, Ye H, et al
    NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner.
    Blood. 2009;113:5217-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. RE A , Michieli M, Casari S, Allione B, et al
     High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long term results of the GICAT study with analysis of prognostic factors.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. GOLDENBERG DM
     Some like it hot: lymphoma radioimmunotherapy.
     Blood. 2009;113:4823-4.
     PubMed     Text format     Related articles   
     
     
     
102. LONG HM , Zuo J, Leese AM, Gudgeon NH, et al
     CD4+ T cell clones recognising human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. VAN LEEUWEN MT , Grulich AE, Webster AC, McCredie MR, et al
     Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. NOVAK U , Rinaldi A, Kwee I, Nandula SV, et al
     The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
     Blood. 2009;113:4918-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. PAGEL JM , Orgun N, Hamlin DK, Wilbur DS, et al
     A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.
     Blood. 2009;113:4903-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. DEANGELIS LM
     Primary central nervous system lymphoma: coming or going?
     Blood. 2009;113:4483-4.
     PubMed     Text format     Related articles   
     
     
     
107. SHI P , Lai R, Lin Q, Iqbal AS, et al
     IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. RITZ O , Guiter C, Castellano F, Dorsch K, et al
     Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. FU L , Lin-Lee YC, Pham LV, Tamayo AT, et al
     BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.
     Blood. 2009;113:4627-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. KENNAH E , Ringrose A, Zhou LL, Esmailzadeh S, et al
     Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
     Blood. 2009;113:4646-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. ZHANG J , Jima DD, Jacobs C, Fischer R, et al
     Patterns of microRNA expression characterize stages of human B-cell differentiation.
     Blood. 2009;113:4586-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. LAN Q , Morton LM, Armstrong B, Hartge P, et al
     Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. KCHOUR G , Tarhini M, Kooshyar MM, El Hajj H, et al
     Phase II study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic ATL.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
114. HOGLUND A , Nilsson LM, Forshell LP, Maclean KH, et al
     Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.
     Blood. 2009;113:4281-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. GERBER HP , Kung-Sutherland M, Stone I, Morris-Tilden C, et al
     Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas.
     Blood. 2009;113:4352-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. MARNEROS AG , Grossman ME, Silvers DN, Husain S, et al
     Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia (ATLL) causing skin erosions.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. DUNLEAVY K , Pittaluga S, Czuczman MS, Dave S, et al
     Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B cell lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. ROSSI EA , Goldenberg DM, Cardillo TM, Stein R, et al
     Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. properties of anti-CD20/CD22 antibodies in lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. STEFANOVIC A , Lossos IS
     Extranodal marginal zone lymphoma of the ocular adnexa.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. MALUMBRES R , Sarosiek KA, Cubedo E, Ruiz JW, et al
     Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.
     Blood. 2009;113:3754-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. DAYDE D , Ternant D, Ohresser M, Lerondel S, et al
     Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20.
     Blood. 2009;113:3765-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. DENT AL
     Going retro on lymphoma.
     Blood. 2009;113:3393-4.
     PubMed     Text format     Related articles   
     
     
     
123. KREJSGAARD T , Vetter-Kauczok CS, Woetmann A, Kneitz H, et al
     Ectopic expression of B lymphoid kinase in cutaneous T-cell lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. AI WZ , Tibshirani R, Taidi B, Czerwinski D, et al
     Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. RIBRAG V , Koscielny S, Casasnovas O, Cazeneuve C, et al
     Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
     Blood. 2009;113:3307-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
126. CLIFFORD GM , Rickenbach M, Lise M, Dal Maso L, et al
     Hodgkin lymphoma in the Swiss HIV Cohort Study.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. GOPAL AK , Pagel JM, Fromm JR, Wilbur S, et al
     I-131-anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. CHRISTOPEIT M , Schutte V, Theurich S, Weber T, et al
     Rituximab reduces the incidence of acute graft-versus-host disease.
     Blood. 2009;113:3130-1.
     PubMed     Text format     Related articles   
     
     
     
129. WANG T , Jiang Q, Chan C, Gorski KS, et al
     Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR.
     Blood. 2009;113:2906-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. GIBLIN W , Chatterji M, Westfield G, Masud T, et al
     Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.
     Blood. 2009;113:2965-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. GUPTA M , Dillon SR, Ziesmer SC, Feldman AL, et al
     APRIL mediates follicular lymphoma B cell proliferation and cyclin D1 expression through PI3-kinase regulated mTOR activation.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. DIEZ-MARTIN JL , Balsalobre P, Re A, Michieli M, et al
     Comparable survival between HIV positive and HIV negative non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. BOCCALATTE FE , Voena C, Riganti C, Bosia A, et al
     The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
     Blood. 2009;113:2776-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. HAGNER PR , Mazan-Mamczarz K, Dai B, Corl S, et al
     Alcohol consumption and decreased risk of non-Hodgkin's lymphoma: role of mTOR dysfunction.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. FRANK MJ , Dawson DW, Bensinger SJ, Hong JS, et al
     Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.
     Blood. 2009;113:2478-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. MARTIN-SUBERO JI , Kreuz M, Bibikova M, Bentink S, et al
     New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
     Blood. 2009;113:2488-97.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. BRADFORD PT , Devesa SS, Anderson WF, Toro JR, et al
     Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3,884 cases.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. HORKHEIMER I , Quigley M, Zhu J, Huang X, et al
     Induction of type I IFN is required for overcoming tumor-specific T cell tolerance following stem cell transplantation.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. AKHTARI M , Waller EK
     Howell-Jolly bodies in patients with chronic GVHD.
     Blood. 2009;113:2125.
     PubMed     Text format     Related articles   
     
     
     February 2009
140. O'HARA AJ , Wang L, Dezube BJ, Harrington WJ Jr, et al
     Tumor suppressor micro RNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. HIRAGA J , Tomita A, Sugimoto T, Shimada K, et al
     Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. WHITECROSS KF , Alsop AE, Cluse LA, Wiegmans A, et al
     Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors.
     Blood. 2009;113:1982-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. DE BRUIN ML , Burgers JA, Baas P, van 't Veer MB, et al
     Malignant mesothelioma following radiation treatment for Hodgkin's lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. KURTOVA AV , Tamayo AT, Ford RJ, Burger JA, et al
     Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. JOSHI I , Minter LM, Telfer J, Demarest RM, et al
     Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
     Blood. 2009;113:1689-98.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. BASHEY A , Medina B, Corringham S, Pasek M, et al
     CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation.
     Blood. 2009;113:1581-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. CARLOTTI E , Wrench D, Matthews J, Iqbal S, et al
     Transformation of follicular lymphoma to diffuse large B cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. CALABRO ML , Gasperini P, Di Gangi IM, Indraccolo S, et al
     Anti-neoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. HILCHEY SP , Hyrien O, Mosmann TR, Livingstone AM, et al
     Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. JONES RJ , Gocke CD, Kasamon YL, Miller CB, et al
     Circulating clonotypic B cells in classical Hodgkin's lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
151. SHARKEY RM , Press OW, Goldenberg DM
     A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: Prospects for dual-targeted antibody/radioantibody therapy.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. GOLDENBERG DM , Rossi EA, Stein R, Cardillo TM, et al
     Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody.
     Blood. 2009;113:1062-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. TAM CS , Bassett R, Ledesma C, Korbling M, et al
     Mature results of the MD Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. CHO SH , Goenka S, Henttinen T, Gudapati P, et al
     PARP-14, a member of the B aggressive lymphoma (BAL) family, transduces survival signals in primary B cells.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. BOEHME V , Schmitz N, Zeynalova S, Loeffler M, et al
     CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: An analysis of patients treated in the RICOVER-60 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL).
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. O'SHEA D , O'Riain C, Gupta M, Waters R, et al
     Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. CORNEJO MG , Kharas MG, Werneck MB, Le Bras S, et al
     Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplant models.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. SAUER S , Erba PA, Petrini M, Menrad A, et al
     Expression of the oncofetal ED-B containing fibronectin isoform in hematologic tumors enables ED-B targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients.
     Blood. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. TUN HW , McKinney M
     Differential gene expression of central nervous system lymphoma.
     Blood. 2009;113:267-8.
     PubMed     Text format     Related articles   
     
     
     
160. RUBENSTEIN JL , Shen A, Batchelor TT, Kadoch C, et al
     Differential gene expression in central nervous system lymphoma.
     Blood. 2009;113:266-7.
     PubMed     Text format     Related articles   
     
     
     
161. LEITNER WW , Baker MC, Berenberg TL, Lu MC, et al
     Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen.
     Blood. 2009;113:37-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. VAN DOORN R , van Kester MS, Dijkman R, Vermeer MH, et al
     Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.
     Blood. 2009;113:127-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
163. CHETAILLE B , Bertucci F, Finetti P, Esterni B, et al
     Molecular profiling of classical Hodgkin's lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. MCCANN KJ , Ashton-Key M, Smith K, Stevenson FK, et al
     Primary CNS lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. ANSELL SM
     Wnt-erizing mantle cell lymphoma.
     Blood. 2008;112:4783-4.
     PubMed     Text format     Related articles   
     
     
     
166. ASANO N , Yamamoto K, Tamaru JI, Oyama T, et al
     Age-related EBV-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classical Hodgkin lymphoma in elderly patients.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. TRUMAN LA , Ford CA, Pasikowska M, Pound JD, et al
     CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.
     Blood. 2008;112:5026-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. ILLIDGE TM , Bayne M, Brown NS, Chilton S, et al
     Phase I/II study of fractionated 131I-rituximab in low grade B-cell lymphoma: The effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. CHEN J , Fiskus W, Eaton K, Fernandez P, et al
     Co-treatment with BCL-2 antagonist sensitizes cutaneous T cell lymphoma to lethal action of HDAC7-Nur77 based mechanism.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. COLT JS , Rothman N, Severson RK, Hartge P, et al
     Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. LEVY DS , Kahana JA, Kumar R
     AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. JAFFE ES , Harris NL, Stein H, Isaacson PG, et al
     Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.
     Blood. 2008;112:4384-99.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
173. JOHNSON NA , Boyle M, Bashashati A, Leach S, et al
     Diffuse large B cell lymphoma: reduced CD20 expression is associated with an inferior survival.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. AU WY , Weisenburger DD, Intragumtornchai T, Nakamura S, et al
     Clinical differences between nasal and extranasal NK/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. AMENGUAL JE , Zhang X, Ibrahim S, Gardner LB, et al
     Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone.
     Blood. 2008;112:4359-60.
     PubMed     Text format     Related articles   
     
     
     
176. NAUSCH N , Galani IE, Schlecker E, Cerwenka A, et al
     Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.
     Blood. 2008;112:4080-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. LU X , Malumbres R, Shields B, Jiang X, et al
     PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
     Blood. 2008;112:4098-108.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. SANDER S , Bullinger L, Klapproth K, Fiedler K, et al
     MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
     Blood. 2008;112:4202-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. SCHLIEMANN C , Palumbo A, Zuberbuhler K, Villa A, et al
     Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. BEA S , Salaverria I, Armengol L, Pinyol M, et al
     Uniparental disomies, homozygous deletions, amplifications and target genes in mantle cell lymphoma revealed by integrative high-resolution whole genome profiling.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. YOUNG RM , Hardy IR, Clarke RL, Lundy N, et al
     Mouse models of non-Hodgkins lymphoma reveal Syk as an important therapeutic target.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. ACQUAVIVA J , Chen X, Ren R
     IRF-4 functions as a tumor suppressor in early B-cell development.
     Blood. 2008;112:3798-806.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. LIU FT , Agrawal SG, Movasaghi Z, Wyatt PB, et al
     Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.
     Blood. 2008;112:3835-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
184. KATZENBERGER T , Kalla J, Leich E, Stocklein H, et al
     A distinctive subtype of t(14;18) negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. CHNG WJ , Remstein ED, Fonseca R, Bergsagel PL, et al
     Gene expression profiling of pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma identifies new biological insights with potential diagnostic and therapeutic applications.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. GYAN E , Foussard C, Bertrand P, Michenet P, et al
     High dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: A randomized multicenter study by the GOELAMS. Final results with a median follow-up of nine years
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. MIYAZAKI K , Yamaguchi M, Imai H, Kobayashi T, et al
     Gene expression profiling of peripheral T-cell lymphoma including {gamma}{delta} T-cell lymphoma.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. CARBONE A , Cesarman E, Spina M, Gloghini A, et al
     HIV-associated lymphomas and gamma-herpesviruses.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. HOUOT R , Levy R
     T cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. INOMATA M , Tagawa H, Guo YM, Kameoka Y, et al
     MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. CERCHIETTI LC , Yang SN, Shaknovich R, Hatzi K, et al
     A peptomimetic inhibitor of BCL6 with potent anti-lymphoma effects in vitro and in vivo.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. VAN MALDEGEM F , van Dijk R, Wormhoudt TA, Kluin PM, et al
     The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment.
     Blood. 2008;112:3355-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. PAOLUZZI L , Gonen M, Bhagat G, Furman RR, et al
     The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.
     Blood. 2008;112:2906-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
194. TJON JM , Verbeek WH, Kooy-Winkelaar YM, Nguyen BH, et al
     Defective synthesis or association of T cell receptor chains underlies loss of surface T cell receptor-CD3 expression in enteropathy associated T cell lymphoma.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. BRODY JD , Goldstein MJ, Czerwinski DK, Levy R, et al
     Immunotransplant preferentially expands Teffector cells over Tregulatory cells and cures large lymphoma tumors.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. DI NICOLA M , Zappasodi R, Carlostella C, Mortarini R, et al
     Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B cell lymphoma patients with relapsed and measurable disease: a pilot study.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. MONTESINOS-RONGEN M , Siebert R, Deckert M
     Primary lymphoma of the central nervous system - just DLBCL or not?
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. SALLES G , Mounier N, de Guibert S, Morschhauser F, et al
     Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. MORTON LM , Wang SS, Cozen W, Linet MS, et al
     Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. BRENNAN RM , Burrows SR
     A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis.
     Blood. 2008;112:2589-90.
     PubMed     Text format     Related articles   
     
     
     
201. KHOURI IF
     Response: Choice of conditioning for allogeneic transplantation in follicular lymphoma: nonmyeloablative or high-dose chemotherapy?
     Blood. 2008;112:2586-7.
     PubMed     Text format     Related articles   
     
     
     
202. VAN BESIEN K , Hari P
     Nonmyeloablative conditioning for relapsed follicular lymphoma.
     Blood. 2008;112:2585-6.
     PubMed     Text format     Related articles   
     
     
     
203. SPEER TW
     Fully human monoclonal antibodies and targeted radionuclide therapy.
     Blood. 2008;112:2584-5.
     PubMed     Text format     Related articles   
     
     
     
204. SHAH JJ , Fayad L, Romaguera J
     Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD.
     Blood. 2008;112:2583.
     PubMed     Text format     Related articles   
     
     
     
205. CHIRON D , Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, et al
     Toll-like receptors: lessons to learn from normal and malignant human B cells.
     Blood. 2008;112:2205-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. NEWRZELA S , Cornils K, Li Z, Baum C, et al
     Resistance of mature T cells to oncogene transformation.
     Blood. 2008;112:2278-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. FUKUMOTO R , Andresen V, Bialuk I, Cecchinato V, et al
     In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. GELEBART P , Anand M, Armanious H, Peters AC, et al
     Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. CUTLER C , Stevenson K, Kim HT, Richardson P, et al
     Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. LEBIEN TW , Tedder TF
     B lymphocytes: how they develop and function.
     Blood. 2008;112:1570-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
211. ORZECHOWSKA BU , Powers MF, Sprague J, Li H, et al
     Rhesus macaque rhadinovirus-associated non-Hodgkin's lymphoma: animal model for KSHV associated malignancies.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. KOBE C , Dietlein M, Franklin J, Markova J, et al
     Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first line chemotherapy in advanced-stage Hodgkin lymphoma.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. LAN Q , Lim U, Liu CS, Weinstein SJ, et al
     A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. CHEUNG KJ , Shah SP, Steidl C, Johnson N, et al
     Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. KRISTINSSON SY , Bjorkholm M, Goldin LR, McMaster ML, et al
     Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia patients: A population-based study in Sweden.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. STOLZ C , Hess G, Hahnel PS, Grabellus F, et al
     Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to Rituximab-induced apoptosis.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. LAMPRECHT B , Kreher S, Anagnostopoulos I, Johrens K, et al
     Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3{alpha}
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. CALVO KR , Dabir B, Kovach A, Devor C, et al
     IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. LI YX , Fang H, Liu QF, Lu J, et al
     Clinical features and treatment outcome of nasal-type NK/T cell lymphoma of Waldeyer's ring.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. GOPAL AK , Press OW, Wilbur SM, Maloney DG, et al
     Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
     Blood. 2008;112:830-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
221. KINDLER T , Cornejo MG, Scholl C, Liu J, et al
     K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to {gamma}-secretase inhibitors.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. ARULOGUN SO , Prince HM, Ng J, Lade S, et al
     Long term outcomes of patients with advanced-stage cutaneous T cell lymphoma and large cell transformation.
     Blood. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: